Parents often put parental controls for their kids and keep an eye on their media consumption at all times but often neglect their own usage by a mile. When you are telling kids to not do certain things and then proceed to do it yourself, you send a hypocritical message to kids. They start believing that you are making up rules and they are not that important, because if they were you yourself would’ve been following it! While you may not think that your media usage should be your kid’s business, a new study shows that it has a direct effect on your kids. Not just their mentality, but also what your screen hours show them that the internet is a safe place where they can explore whatever content they want. It is very easy for kids to override the age rule and get access to mature content, which lead to them consuming these videos and media from an early age! A new study looked at how parents' phone use might affect whether their kids see inappropriate content. Researchers found that when parents spend a lot of time on their phones and don't have clear rules about media use at home, their kids are more likely to watch R-rated movies or play video games meant for adults. The study talked to over 10,000 kids aged 12 and 13.
A recent study published in the journal BMC Pediatrics has revealed a potential link between parents' phone habits and their children's consumption of inappropriate content. The researchers wanted to learn more about how parents can help their young teens with media use. They explained that while there's advice for younger kids and older teens, there's not much for this age group. These young teens are in a tricky stage, they're not little kids anymore, but they're not quite teenagers either. The study wanted to see how what parents do and the rules they make affect what kind of content young teens are exposed to.
Parents answered questions about their own phone use, like how often they try to limit their screen time around their kids. The kids also answered questions about how often they watch R-rated movies or play mature video games. The study found that the more time parents spent on their phones, the more likely their kids were to consume mature content. Things like using phones during meals or in bedrooms seemed to be especially linked to kids seeing this type of content.
Experts say it's important for parents to be aware of their own phone habits, because kids often copy what they see. They suggest that parents should "practice what they preach", if they make a rule about no phones at the dinner table, they should follow it too. Experts also recommend that families create a media plan together with clear rules, like limiting screen time during meals and before bed, talking about what they see online, not using screen time as punishment, and using it as a reward for good habits. Basically, the study shows that what parents do with their phones can really influence what their kids are doing online.
First, see how much you're using them and set small goals to cut back. Make some areas and times in your house phone-free, like during meals and before sleep, this is a great chance to connect with your family. Turn off notifications you don't need and find fun things to do instead of being on your phone, maybe even things your family can do together. Put your phone away so it's not always tempting and think about why you're picking it up. Tell your family you're trying to use your phone less, and maybe they'll join you! If it's tough, think about taking a break from all screens for a bit. It takes time, so be patient with yourself and enjoy the extra time you have with your family. This not only benefits you but also sets a positive example for your children.
Credit: iStock
As oncologists, we often meet patients at some of the most difficult moments of their lives. Yet there are times where a patient's journey reminds of the extraordinary resilience that people can show while facing the challenges that cancer presents
I recently treated a 38-year-old woman whose story has stayed with me.
Having just welcomed her baby into the world, her demanding yet joyful routine revolved around feeding schedules and sleepless nights. It was during this period that she noticed a hard lump in her breast.
A sonomammography revealed a suspicious BIRADS 4A lesion. A biopsy confirmed Triple-Negative Breast Cancer (TNBC), which is one of the more aggressive forms of breast cancer. It was classified as a Stage III disease after evaluation through PET-CT which showed involvement of the axillary lymph nodes. The tumor also had a high Ki-67 index, indicating that it was growing rapidly.
The untimely diagnosis found the mother facing difficult questions about cancer treatment, her future and her ability to care for her child. One of the immediate challenges was that she had to stop breastfeeding.
Under the guidance of her pediatrician, her baby was transitioned to bottle feeds. This can be an emotionally challenging process for mothers as the feeling of guilt tends to seep in when breastfeeding plans are disrupted by illness.
After detailed and prolonged discussions with the patient and her family, we initiated treatment with neoadjuvant immunotherapy using pembrolizumab in combination with chemotherapy. This approach has emerged as one of the more prominent advances in the treatment of high-risk Triple-Negative Breast Cancer, having significantly improved outcomes for many patients.
Motherhood is a physically and emotionally taxing experience but the patient showed incredible strength during her cancer therapy, driven by her child and the unwavering support of her family.
Following completion of neoadjuvant therapy, repeat PET-CT imaging showed a near-complete response. She subsequently underwent surgery, and the final pathology report revealed a pathological complete response, meaning no residual invasive cancer had been detected.
This was the desired outcome for the treating team as well as the patient. She later completed the remaining course of immunotherapy, bringing her total treatment duration to one year. Today, both mother and child are doing well.
This tremendous journey highlights an important message. The fact that breast cancer can occur during pregnancy and the postpartum period deserves wider attention. Any breast lump that persists or feels unusual should be evaluated by a healthcare professional, as early diagnosis remains one of the most important factors in achieving positive outcomes.
The process is reflective of the advances in cancer treatment that are changing the outlook for patients with aggressive cancers. These advances are done through the integration of immunotherapy into treatment protocols which is helping more patients achieve improved long-term outcomes. The mother’s story is a reminder that cancer and motherhood are not mutually exclusive journeys.
Her ability to navigate this path is due to her timely diagnosis, access to appropriate treatment, family support and personal resilience. What began as a frightening diagnosis soon after childbirth ultimately became a story of hope, courage and survival. This is a powerful reminder to every new mother who might discover an unusual breast lump, that listening to your body and seeking medical advice early can make all the difference.
Credit: iStock
Pregnancy should not be regarded as a physical journey since it is a very emotional and deeply transformative phase in any woman's life. As the body changes itself to support new life, expecting mothers usually experience pain in the back, fatigue, and breathing-related discomfort. When practised under proper medical guidance, prenatal yoga can be very safe and highly supportive throughout pregnancy.
As pregnancy progresses, the center of gravity of the body is shifted by the growing uterus. This can even impact posture and overall movement of the body. Prenatal Yoga normally includes gentle stretches and a controlled level of movement, which helps to improve the flexibility and stability without even placing unnecessary strain on the mother's and baby's bodies.
Credit: Canva
India’s Union Ministry of Health and Family Welfare has issued a notification ending the over-the-counter (OTC) sale of all syrups, including cough syrups.
Under the new rules, a doctor's prescription will now be required to purchase cough syrups across the country.
“Consequently, the sale and dispensing of cough syrups in smaller villages will now be required to take place only through duly licensed pharmacies in accordance with the provisions of the Drugs and Cosmetics Act, 1940 and the Rules framed thereunder,” the notification said.
The amendment comes months after contaminated cough syrups were linked to the deaths of 22 children in Madhya Pradesh and Rajasthan, raising fresh concerns over the safety and regulation of commonly used liquid medicines.
Following the incident last year, health authorities in India had banned three cough syrups Coldrif, Respifresh TR and ReLife after traces of diethylene glycol (DEG) were detected in the products. The Coldrif contamination was linked to the deaths of 22 children in the country.
“The amendment has been undertaken to strengthen regulatory oversight of syrup formulations and to align the exemption framework with contemporary public health and safety requirements,” the notification said.
“The measure is expected to promote responsible distribution and sale of cough syrups while ensuring greater compliance with regulatory standards across the country,” it added.
Also read: Introducing Eggs Before Age One May Lower Allergy Risk by 17%, Says Study
Dr Kuldeep Kumar Grover, Associate Director, Pulmonology and Critical Care, CK Birla Hospital, Gurugram called it a
"a good initiative to include all syrup varieties, cough syrups included, under prescription medicines".
Cough syrups have substances that might lead to drowsiness, addiction, or drug interaction in patients who do not seek medical advice before taking the medicines.
"It is important to note that a cough could be a symptom of other serious conditions like infections, asthma, and allergies. Prescription-based access encourages proper evaluation, accurate treatment, and safer medication use," Grover said.
Dr. (Prof.) Mohsin Wali, former Physician to the President of India, said cough syrups and similar formulations often contain suppressants such as codeine and dextromethorphan (DXM), along with other solvents.
Dr. Wali, Senior Consultant and Head of Preventive Cardiology at Pacific One Health, recalled previous incidents in which contaminated Indian-made cough syrups were linked to deaths in Gambia and other African countries.
"Industrial-grade solvents were detected in some of these products, leading to kidney failure, severe metabolic acidosis, and, in some cases, death," he said.
According to Dr. Wali, the new notification will help curb the overuse, misuse, and addictive use of cough syrups while improving patient safety.
The Ministry notified an amendment to the Drugs Rules, 1945, through Gazette Notification G.S.R. 927(E) dated December 29, 2025, published in the Gazette of India Extraordinary, Part II, Section 3, Sub-section (i), dated December 30, 2025.
The amendment omits the word “Syrup” from Schedule K, Serial No. 13, Entry 7 under the heading “Class of Drugs.”
Schedule K of the Drugs Rules, 1945, provides exemptions from certain provisions of the Drugs and Cosmetics Act, 1940, and the rules framed under it for specified classes of drugs.
Before this amendment, Entry No. 13 of Schedule K permitted the sale of cough syrups in villages with a population of less than 1,000 without requiring compliance with certain retail sale licensing provisions.

With the omission of the word “Syrup” from the entry, this exemption will no longer apply to cough syrups.
Manufacturers, distributors, and retailers dealing with cough syrups have been advised to ensure strict compliance with the applicable licensing and regulatory requirements under the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.
Last year, India formally prohibited the use of certain commonly available OTC cough and cold medicines in children below the age of four.
The policy move, notified through a gazette notification, banned a fixed-dose combination (FDC) of Chlorpheniramine Maleate and Phenylephrine Hydrochloride—two ingredients commonly found in pediatric cough syrups.
The decision followed growing global concerns over the safety of these medicines in very young children, with India joining several countries that have introduced stricter regulations.
Countries including the United States, Canada, and the United Kingdom had previously issued guidelines or warnings regarding the use of OTC cough and cold medicines in young children.
© 2024 Bennett, Coleman & Company Limited